Breaking News Instant updates and real-time market news.

THC

Tenet

$21.67

0.59 (2.80%)

, HCA

HCA Healthcare

$120.15

-0.235 (-0.20%)

09:21
09/03/19
09/03
09:21
09/03/19
09:21

Evercore says Tenet has highest exposure among hospitals to Dorian's new path

Evercore ISI analyst Michael Newshel estimates that Tenet (THC) has 22% of its beds in coastal counties in Florida, Georgia, South Carolina and North Carolina, where mandatory evacuations have been ordered in certain coastal areas due to the expected path of Hurricane Dorian. HCA Healthcare (HCA) has 15% of its beds in coastal counties in Florida, George and South Carolina, including 8% in counties that have received evacuation orders, while Universal Health (UHS) has one acute hospital, representing 3.6% of its total acute beds, in the affected coastal counties, and 8% of its behavioral beds are in coastal counties, the analyst noted. Newshel said Community Health (CYH), Quorum Health (QHC) and Acadia (ACHC) do not have any coastal exposure in the four states expected to be most impacted by Dorian.

THC

Tenet

$21.67

0.59 (2.80%)

HCA

HCA Healthcare

$120.15

-0.235 (-0.20%)

UHS

Universal Health

$144.74

0.8 (0.56%)

CYH

Community Health

$2.48

0.325 (15.08%)

QHC

Quorum Health

$1.00

0.0458 (4.82%)

ACHC

Acadia

$26.44

-0.1 (-0.38%)

  • 04

    Sep

  • 04

    Sep

  • 09

    Sep

  • 23

    Sep

  • 13

    Nov

THC Tenet
$21.67

0.59 (2.80%)

05/01/19
RHCO
05/01/19
NO CHANGE
Target $27
RHCO
Hold
Tenet price target lowered to $27 from $34 at SunTrust
SunTrust analyst David MacDonald lowered his price target on Tenet to $27 to reflect lower market multiples in the industry. The analyst also keeps his Hold rating on the stock, saying that while the company's Q1 results saw solid volume trends and progress on the management's efficiency initiatives, he sees "continued operational execution and free cash flow generation" as key.
08/14/19
08/14/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tenet (THC) reinstated with a Neutral at Goldman Sachs. 2. WWE (WWE) initiated with a Buy at Rosenblatt. 3. iHeartMedia (IHRT) initiated with a Buy at BofA/Merrill. 4. Fastly (FSLY) initiated with an Overweight at Piper Jaffray. 5. Amarin (AMRN) initiated with an Outperform at SVB Leerink. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/17/19
SPHN
04/17/19
NO CHANGE
SPHN
Issues facing healthcare sector now 'modest' compared to 2008-10, says Stephens
Stephens analyst Scott Fidel noted that the managed care group has sharply underperformed the S&P 500 over the last month amid "political rhetoric" around point-of-sale drug rebates and Medicare for all policy proposals, though he believes the issues facing the sector right now "seem modest in comparison" to the "dark days of 2008-2010." While recent Medicare for all proposals have rattled investors, "they will face enormous uphill battles," Fidel tells investors. Hospital stocks have outperformed MCOs year-to-date, but the group declined about 9% yesterday and underperformed the MCO group, which Fidel attributes to acknowledgement by industry bellwether UnitedHealth (UNH) of the significant disruptive nature of Medicare for all, which may have sparked additional fears, as well as one less calendar day being called out by UnitedHealth as benefiting Q1 MLRs and Johnson & Johnson's (JNJ) earnings call commentary on declining sequential hospital admissions from Q4. Publicly traded companies in the hospital space include Community Health (CYH), HCA Healthcare (HCA), LifePoint (LPNT), Tenet (THC) and Universal Health (UHS). Publicly traded companies in the managed care space include Anthem (ANTM), CVS Health (CVS), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
08/14/19
GSCO
08/14/19
INITIATION
Target $28
GSCO
Neutral
Tenet reinstated with a Neutral at Goldman Sachs
Goldman Sachs analyst Stephen Tanal reinstated coverage of Tenet Healthcare with a Neutral rating and $28 price target following the conclusion of its strategic review for Conifer. The analyst believes the risk/reward for Tenet's shares look favorable ahead of the proposed Conifer spin, but he looks for signs of sustainability in improved Q2 hospital volumes and better flow-through to earnings growth.
HCA HCA Healthcare
$120.15

-0.235 (-0.20%)

07/31/19
MZHO
07/31/19
NO CHANGE
Target $153
MZHO
Buy
HCA Healthcare selloff yesterday an overreaction, says Mizuho
Mizuho analyst Ann Hynes views the 9% post-earnings selloff yesterday in shares of HCA Healthcare as an overreaction. Expectations were high for a beat and a meaningful guidance raise going into the Q2 report given the significant outperformance in Q1, and HCA did not meet those expectations, Hynes tells investors in a research note. The analyst, however, does not believe there is any fundamental change to HCA's business. She keeps a Buy rating on the shares with a $153 price target.
07/10/19
07/10/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Comcast (CMCSA) upgraded to Conviction Buy from Neutral at Goldman Sachs with analyst Brett Feldman saying he estimates Comcast will sustain "strong growth" over next three years with annual earnings growth of 11%, free cash flow per share of 12% and dividends of 15%, driven by "healthy fundamentals across its key businesses." 2. Total (TOT) upgraded to Outperform from Neutral at Credit Suisse with analyst Thomas Adolff saying he believes the company's Strategy Day in September will serve as a catalyst. 3. DMC Global (BOOM) upgraded to Buy from Neutral at Sidoti. 4. Core Laboratories (CLB) upgraded to Buy from Neutral at BofA/Merrill with analyst Chase Mulvehill saying he sees the stock being set to reverse its outperformance after having fallen 10% year-to-date. 5. HCA Healthcare (HCA) upgraded to Buy from Neutral at Goldman Sachs with analyst Stephen Tanal saying he has a "greater appreciation for the resiliency" of the economic model of certain acute hospitals, notably HCA. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/10/19
GSCO
07/10/19
UPGRADE
Target $160
GSCO
Buy
Goldman upgrades HCA Healthcare to Buy, boosts priced target to $160
Goldman Sachs analyst Stephen Tanal upgraded HCA Healthcare (HCA) to Buy from Neutral and raised his price target for the shares to $160 from $147. After deep dive of local market competitive dynamics and market share patterns of hospitals, the analyst has a "greater appreciation for the resiliency" of the economic model of certain acute hospitals, notably HCA. The company, and certain other hospital systems, have sufficient bargaining power at the local level to mitigate the effects of any potential negative policy actions taken by government agencies, Tanal tells investors in a research note. The analyst keeps Sell ratings on both Community Health (CYH) and Universal Health (UHS).
07/10/19
GSCO
07/10/19
UPGRADE
Target $160
GSCO
Buy
HCA Healthcare upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Stephen Tanal upgraded HCA Healthcare to Buy from Neutral and raised his price target for the shares to $160 from $147.
UHS Universal Health
$144.74

0.8 (0.56%)

07/29/19
FBCO
07/29/19
NO CHANGE
Target $170
FBCO
Outperform
Universal Health price target raised to $170 from $150 at Credit Suisse
Credit Suisse analyst A.J. Rice raised his price target for Universal Health to $170 from $150 following quarterly results. The analyst reiterates an Outperform rating on the shares.
06/07/19
UBSW
06/07/19
NO CHANGE
Target $151
UBSW
Buy
Universal Health price target lowered to $151 from $161 at UBS
UBS analyst Whit Mayo lowered his price target on Universal Health to $151 but kept his Buy rating on the shares after meeting with its CFO. The analyst notes that he is "struggling" to assess the company's potential for 2019, but the commentary from the management was "broadly positive", maintaining its stance that "stronger medical and weaker surgical trends" reported in Q1 were "transitory", with recent capital projects making the targets for the year achievable.
07/30/19
RBCM
07/30/19
NO CHANGE
Target $165
RBCM
Outperform
Universal Health price target raised to $165 from $143 at RBC Capital
RBC Capital analyst Frank Morgan raised his price target on Universal Health to $165 after its Q2 earnings beat and a deal reached with the Department of Justice that resolves the government's investigation of the company's behavioral health care facilities. With the overhang eliminated, the analyst contends that the bias for Universal Health Services' FY19 performance is now to the upside, keeping his Outperform rating on the stock.
CYH Community Health
$2.48

0.325 (15.08%)

12/28/18
PIPR
12/28/18
NO CHANGE
PIPR
Piper says buy Centene, sell Community Health if recession were to occur
After performing a recession risk/reward for Hospitals and Managed Care Organizations, Piper Jaffray analyst Sarah James recommends buying Centene (CNC) and selling Community Health Systems (CYH) if a recession were to occur. The analyst says that with some economists calling for a recession in 2019, she dug into the potential impacts across the hospital and insurance sector. For hospitals, consumer surveys point to economic outlook impacting decisions to receive services, James tells investors in a research note. On the other hand, insurers are a "natural defensive sector in a recession," adds the analyst. As such, in a recession James would be adding exposure to insurers and lightening hospitals.
11/15/18
UBSW
11/15/18
INITIATION
UBSW
HCA Healthcare, Encompass Health, Universal Health initiated with Buy at UBS
UBS analyst Whit Mayo launched coverage of Healthcare Facilities with a broader research note titled "Navigating an Evolving Landscape - Who Will Be Left?". The analyst is most bullish on stocks that "discount the perceived secular sector headwinds" such as Buy-rated HCA Healthcare (HCA), Encompass Health (EHC), and Universal Health (UHS), adding that investors also under-appreciate the accelerating free-cash flow profiles of these companies. Mayo differentiates HCA Healthcare based on its 0% correlation in national hospital utilization trends against public results. The analyst is also bullish on LHC Group (LHCG), stating that its same-property admission growth projections are higher than the rest. Mayo rates Community Health Systems (CYH), DaVita (DVA), and Mednax (MD) at a Sell with a bearish view of dialysis, births, and inpatient surgery end-markets. The analyst sees Community Health Systems same-property volume trend at a relatively low rate. Mayo also gives Acadia (ACHC), Amedisys (AMED), Surgery Partners (SGRY), and Tenet (THC) a Neutral rating as part of this research note based on their relative valuation as a factor of same-property volume growth.
QHC Quorum Health
$1.00

0.0458 (4.82%)

05/13/19
RBCM
05/13/19
NO CHANGE
Target $2
RBCM
Sector Perform
Quorum Health price target lowered to $2 from $6 at RBC Capital
RBC Capital analyst Frank Morgan lowered his price target on Quorum Health to $2 after its Q1 earnings miss that was driven by softer than expected volumes, even though the analyst believes that the volume disruptions have normalized this quarter. The analyst calls the Q1 miss disappointing, but also notes that contributions from the company's "new opportunities" not reflected in the original guidance have allowed Quorum Health Management to maintain its outlook. Morgan keeps his Sector Perform rating on the shares.
ACHC Acadia
$26.44

-0.1 (-0.38%)

04/23/19
SBSH
04/23/19
NO CHANGE
SBSH
Buy
Citi opens 'Positive Catalyst Watch' on Acadia for potential asset sale
Citi analyst Ralph Giacobbe opened a "Positive Catalyst Watch" on Acadia Healthcare following headlines suggesting the company is seeking a sale of its U.K. business, and specifically the Priory assets for $1.3B. The analyst sees "some optionality," whether it is an outright sale of Priory or select asset sales in the region. He keeps a Buy rating on the shares.
03/04/19
JEFF
03/04/19
NO CHANGE
Target $40
JEFF
Buy
Acadia guidance acheivable, possibly conservative, says Jefferies
Jefferies analyst Brian Tanquilut said the articulation from Acadia Healthcare management of the bridge from Q4 earnings to 2019 EBITDA guidance underscored the achievability, and possibly even conservatism, of the company's outlook. Additionally, the company's strategic review of the U.K. segment provides a potential positive catalyst in the near-term, said Tanquilut, who has a Buy rating and $40 price target on Acadia shares.
01/03/19
DBAB
01/03/19
INITIATION
Target $27
DBAB
Hold
Acadia initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Pito Chickering started Acadia Healthcare with a Hold rating and $27 price target. The analyst initiated coverage on Healthcare Facilities with a constructive view saying the sector is "relatively defensive" in slowing business cycles and that company cash flows "provide downside protection in volatile markets."
07/31/19
RAJA
07/31/19
DOWNGRADE
Target $45
RAJA
Outperform
Acadia downgraded to Outperform from Strong Buy at Raymond James
Raymond James analyst John Ransom downgraded Acadia Healthcare to Outperform from Strong Buy with a $45 price target. The analyst sees risk to Q3 estimates and ongoing uncertainty in the U.K. following the company's Q2 results.

TODAY'S FREE FLY STORIES

TEL

TE Connectivity

$93.21

-1.21 (-1.28%)

05:34
09/23/19
09/23
05:34
09/23/19
05:34
Downgrade
TE Connectivity rating change  »

TE Connectivity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWDBY

Swedbank

$0.00

(0.00%)

05:33
09/23/19
09/23
05:33
09/23/19
05:33
Upgrade
Swedbank rating change  »

Swedbank upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESLOY

EssilorLuxottica

$0.00

(0.00%)

05:32
09/23/19
09/23
05:32
09/23/19
05:32
Upgrade
EssilorLuxottica rating change  »

EssilorLuxottica upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHWY

Chewy

$26.44

-1.06 (-3.85%)

05:30
09/23/19
09/23
05:30
09/23/19
05:30
Upgrade
Chewy rating change  »

Chewy upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEXAY

Atos

$0.00

(0.00%)

05:29
09/23/19
09/23
05:29
09/23/19
05:29
Upgrade
Atos rating change  »

Atos upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$238.80

3.2 (1.36%)

05:28
09/23/19
09/23
05:28
09/23/19
05:28
Hot Stocks
Biogen says Plegridy, Avonex receive 'positive opinion' from CHMP »

Biogen announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

ACN

Accenture

$192.99

-1.78 (-0.91%)

05:28
09/23/19
09/23
05:28
09/23/19
05:28
Initiation
Accenture initiated  »

Accenture initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Oct

TELDF

Telefonica Deutschland

$0.00

(0.00%)

05:27
09/23/19
09/23
05:27
09/23/19
05:27
Upgrade
Telefonica Deutschland rating change  »

Telefonica Deutschland…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGY

VAALCO Energy

$2.08

0.06 (2.97%)

05:26
09/23/19
09/23
05:26
09/23/19
05:26
Initiation
VAALCO Energy initiated  »

VAALCO Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$11.64

-0.565 (-4.63%)

05:25
09/23/19
09/23
05:25
09/23/19
05:25
Hot Stocks
PG&E expects to turn off power late Monday in nine CA counties due to fire risk »

Pacific Gas and Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Oct

  • 10

    Nov

  • 10

    Nov

  • 07

    Jan

AIBRF

AIB Group

$0.00

(0.00%)

05:25
09/23/19
09/23
05:25
09/23/19
05:25
Upgrade
AIB Group rating change  »

AIB Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAOFY

Tatneft

$0.00

(0.00%)

05:22
09/23/19
09/23
05:22
09/23/19
05:22
Downgrade
Tatneft rating change  »

Tatneft downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESYJY

easyJet

$0.00

(0.00%)

05:21
09/23/19
09/23
05:21
09/23/19
05:21
Upgrade
easyJet rating change  »

easyJet upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLOWY

Vallourec

$0.00

(0.00%)

05:20
09/23/19
09/23
05:20
09/23/19
05:20
Downgrade
Vallourec rating change  »

Vallourec downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TELNY

Telenor

$0.00

(0.00%)

05:15
09/23/19
09/23
05:15
09/23/19
05:15
Downgrade
Telenor rating change  »

Telenor downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANNSF

Aena

$0.00

(0.00%)

05:14
09/23/19
09/23
05:14
09/23/19
05:14
Downgrade
Aena rating change  »

Aena downgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.69

-3.22 (-1.46%)

05:13
09/23/19
09/23
05:13
09/23/19
05:13
Recommendations
Apple analyst commentary  »

Piper survey shows higher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXCM

DexCom

$154.45

-0.49 (-0.32%)

, ABT

Abbott

$83.56

0.35 (0.42%)

05:04
09/23/19
09/23
05:04
09/23/19
05:04
Recommendations
DexCom, Abbott analyst commentary  »

DexCom remains a…

DXCM

DexCom

$154.45

-0.49 (-0.32%)

ABT

Abbott

$83.56

0.35 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 16

    Oct

  • 13

    Nov

EW

Edwards Lifesciences

$219.56

4.45 (2.07%)

04:58
09/23/19
09/23
04:58
09/23/19
04:58
Initiation
Edwards Lifesciences initiated  »

Edwards Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITW

Illinois Tool Works

$155.05

-0.91 (-0.58%)

, HON

Honeywell

$168.42

1.7 (1.02%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Downgrade
Illinois Tool Works, Honeywell rating change  »

Illinois Tool Works…

ITW

Illinois Tool Works

$155.05

-0.91 (-0.58%)

HON

Honeywell

$168.42

1.7 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

HR

Healthcare Realty Trust

$33.17

-0.155 (-0.47%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Healthcare Realty Trust management to meet with Capital One »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

NBIX

Neurocrine

$100.74

-0.77 (-0.76%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Neurocrine participates in a conference call with JPMorgan »

SMid Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

SIBN

SI-Bone

$20.18

0.28 (1.41%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
SI-Bone management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

TXN

Texas Instruments

$126.70

-2.1 (-1.63%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Texas Instruments management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

CLDR

Cloudera

$9.00

0.33 (3.81%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Cloudera management to meet with Needham »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.